The New York Times Admits Scientists Can Be Bought
...And this headline: "Coca-Cola Funds Scientists Who Shift Blame for Obesity Away From Bad Diets." This is also the New York Times....
...If Coca-Cola can find scientists and get an opinion that they want from by paying them, do you think the same thing could happen to climate change scientists and a "consensus" of them? Do you think somebody could come along and offer those scientists enough money? I mean, the left, if anybody's paying attention, is writing their own obituary in this stuff. ...
...Do you know that climate change has become an industry? It is a $1.5 trillion industry. This is from an insurance website. They know this because all of these various industries have to buy insurance policies and the value of these policies is $1.5 trillion. "Interest in climate change is becoming an increasingly powerful economic driver, so much so that some see it as an industry in itself whose growth is driven in large part by policymaking. The $1.5 trillion global 'climate change industry' grew at between 17 and 24% annually from 2005-2008," and there are more details on this coming later. ...
6 Reasons You Can't Trust Science Anymore
Is Climate Change Now Its Own Industry?
...Included in this sub-segment, which the report shows is one of the fastest growing areas of the climate change industry, are environmental consultants and engineers, risk managers, assurance, as well as legal and other professional services....
Registered clinical trials make positive findings vanish
...A 1997 US law mandated the registry’s creation, requiring researchers from 2000 to record their trial methods and outcome measures before collecting data. The study found that in a sample of 55 large trials testing heart-disease treatments, 57% of those published before 2000 reported positive effects from the treatments. But that figure plunged to just 8% in studies that were conducted after 2000. Study author Veronica Irvin, a health scientist at Oregon State University in Corvallis, says this suggests that registering clinical studies is leading to more rigorous research. Writing on his NeuroLogica Blog, neurologist Steven Novella of Yale University in New Haven, Connecticut, called the study “encouraging” but also “a bit frightening” because it casts doubt on previous positive results....
...Irvin says that by having to state their methods and measurements before starting their trial, researchers cannot then cherry-pick data to find an effect once the study is over. “It’s more difficult for investigators to selectively report some outcomes and exclude others,” she says....
